40,15EUR | +0,05 EUR | +0,12 %
DAX-0,54 % EUR/USD+0,14 % Gold+0,68 % Öl (Brent)-0,13 %

The Must-Know Cannabis Stocks Before Vapes Hit Canadian Shelves in December 2019

Nachrichtenquelle: PR Newswire (engl.)
10.07.2019, 14:50  |  542   |   |   

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, July 10, 2019 /PRNewswire/ -- Consumer buying habits are shifting, as the cannabis industry evolves.  As that happens, investors are being offered incredible opportunities.  For example, according to GMP Securities, "demand for extracted products is going to explode this fall with the arrival of vape pens and infused products," as quoted by Marijuana Business Daily, adding that vape pens could lead with 20% of the extracts sector.  In addition, Aphria Inc. says, "The expected legalization of vapes and concentrates will mark a significant turning point in the Canadian market, providing more choice and new experiences, while opening the door to a range of new consumers," adding that vapes and concentrates will represent close to 30% of the entire Canadian adult-use market by 2021. Better, Canadian consumers will be able to buy edibles, concentrates, and vape pens in mid to late December 2019 after Health Canada released the final version of regulations. That's opening a wide range of opportunity for companies including Vapen MJ Ventures (CSE: VAPN), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), Aphria Inc. (NYSE:APHA) (TSX: APHA), and GW Pharmaceuticals PLC (NASDAQ: GWPH).

Vapen MJ Ventures (CSE: VAPN) BREAKING NEWS: Vapen MJ Ventures just announced the launch of their exclusive THC-Free CBD Inhalers. The inhalers feature technology for a precisely metered dose of THC-free, pharmaceutical grade CBD. The line offers three flavors, Raw, Bubblegum and Strawberry, and is available in 1,000 milligram (mg) canisters that deliver 10 mg per puff for a total of 100 puffs per inhaler. Vapen's CBD inhaler technology is the best way to get a precisely measured and controlled dose of CBD. Vapen CBD inhalers are convenient and effective with a rapid absorption rate to deliver relief quickly. Each inhaler is produced by hand at Vapen's U.S. facility to ensure accuracy and are third-party Lab Certified for purity and quality control. 

"Vapen CBD makes premium pure, organic and bioavailable broad spectrum and isolate CBD products from our state-of-the-art facility in Phoenix, Arizona. We are passionate about delivering pure quality CBD products that make you feel better," commented Thai Nguyen, Founder and Chief Executive Officer of Vapen MJ Ventures. "Expanding our product lines into the rapidly growing CBD market will strengthen the Vapen brand and expand our market reach to consumers seeking CBD benefits. This strategy aligns with our long-term growth plans to enhance our product offering, increase our brand awareness, and grow our distribution to drive shareholder value." For more info, please visit:  https://vapencbd.com/

Diesen Artikel teilen

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Meistgelesene Nachrichten des Autors